{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:25:36Z","timestamp":1783689936430,"version":"3.55.0"},"reference-count":70,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>There have been several Viral Hemorrhagic Fever (VHF) outbreaks in Nigeria which remains a public health concern. Despite the increasing number of suspected cases of VHF due to heightened surveillance activities and growing awareness, only a few cases are laboratory-confirmed to be VHF. Routinely, these samples are only tested for Lassa virus and Yellow fever virus with occasional testing for Dengue virus when indicated. The aetiology of the disease in these VHF suspected cases in Nigeria which are negative for Lassa, Yellow fever and Dengue viruses remains a puzzle. Since the clinical features exhibited by suspected VHF cases are like other endemic illnesses such as Hepatitis, there is a need to investigate the diversity and co-infections of hepatitis viruses as differentials and possible co-morbidity in suspected cases of VHFs in Nigeria. A total of three hundred and fifty (350) blood samples of 212 (60.6%) males and 138 (39.4%) females, aged &lt;1\u201370 years with a mean age of 25 \u00b114.5, suspected of VHFs and tested negative for Lassa, Yellow fever and Dengue viruses were investigated for Hepatitis A, B, C and E viruses at the Centre for Human and Zoonotic Virology (CHAZVY), College of Medicine, University of Lagos (CMUL) using serologic and molecular techniques. The serologic analysis of these VHF suspected cases samples revealed that 126 (36%) were positive for at least one hepatitis virus. Individual prevalence for each of the hepatitis virus screened for showed that 37 (10.6%), 18 (5.1%) and 71 (20.3%) were positive for HBV, HCV and HEV respectively. All the samples were negative for HAV. A co-infection rate of 11.9% was also observed, with HCV\/HEV co-infections being the most prevalent and the Northern region having the greatest burden of infection. The evidence of hepatitis virus infections in suspected cases of VHF was documented. Thus, their associations as co-morbidities and\/or mortalities in this category of individuals require further investigations in endemic countries such as Nigeria. Therefore, the possible inclusion of screening for hepatitis viruses and other aetiologic agents that could mimic infections in suspected cases of VHFs in Nigeria should be thoroughly evaluated to guide informed policy on the diagnosis and management of these cases.<\/jats:p>","DOI":"10.1371\/journal.pone.0305521","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T17:49:35Z","timestamp":1718992175000},"page":"e0305521","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Detection of hepatitis viruses in suspected cases of Viral Haemorrhagic Fevers in Nigeria"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2683-3521","authenticated-orcid":true,"given":"Olumuyiwa Babalola","family":"Salu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomilola Feyikemi","family":"Akinbamiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remilekun Mercy","family":"Orenolu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onyinye Dorothy","family":"Ishaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roosevelt Amaobichukwu","family":"Anyanwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olubunmi Rita","family":"Vitowanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam Abiodun","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adenike Hellen","family":"Olowoyeye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sodiq Olawale","family":"Tijani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kolawole Solomon","family":"Oyedeji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunday Aremu","family":"Omilabu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,6,21]]},"reference":[{"issue":"9","key":"pone.0305521.ref001","doi-asserted-by":"crossref","first-page":"e2435","DOI":"10.1371\/journal.pntd.0002435","article-title":"Hospital-Based Surveillance for Viral Hemorrhagic Fevers and Hepatitides in Ghana","volume":"7","author":"JHK Bonney","year":"2013","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"pone.0305521.ref002","unstructured":"Nigeria Centre for Disease Control (NCDC). National Guidelines on Infection Prevention and Control of Viral Hemorrhagic Fevers. 2018. Available from: https:\/\/ncdc.gov.ng\/themes\/common\/docs\/protocols\/92_1547068532.pdf"},{"issue":"5","key":"pone.0305521.ref003","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.jhep.2022.06.031","article-title":"Exotic viral hepatitis: A review on epidemiology, pathogenesis, and treatment","volume":"77","author":"LPM van Leeuwen","year":"2022","journal-title":"J Hepatol"},{"issue":"2","key":"pone.0305521.ref004","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/cid\/civ792","article-title":"Viral Haemorrhagic Fever Diagnostics","volume":"62","author":"DL Racsa","year":"2016","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"pone.0305521.ref005","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/s13256-021-03069-w","article-title":"Co-infection with dengue and hepatitis A complicated with infective endocarditis in a Yemeni patient: a case report","volume":"15","author":"SA Alemad","year":"2021","journal-title":"J Med Case Rep"},{"key":"pone.0305521.ref006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1874357901610010001","article-title":"Viruses Causing Hemorrhagic Fever. Safety Laboratory Procedures","volume":"10","author":"F. Cobo","year":"2016","journal-title":"Open Virol J"},{"key":"pone.0305521.ref007","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jhin.2012.10.013","article-title":"Viral haemorrhagic fevers in healthcare settings","volume":"83","author":"L Ftika","year":"2013","journal-title":"J Hosp Infect"},{"key":"pone.0305521.ref008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40794-020-0101-0","article-title":"Yellow fever control: Current epidemiology and vaccination strategies. Trop. Dis","volume":"6","author":"LH Chen","year":"2020","journal-title":"Travel Med. Vaccines"},{"key":"pone.0305521.ref009","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3390\/v13081475","article-title":"Yellow Fever Outbreak in Eastern Senegal, 2020\u20132021","volume":"13","author":"M Diagne","year":"2021","journal-title":"Viruses"},{"key":"pone.0305521.ref010","first-page":"34","article-title":"Lassa virus RNA detection from suspected cases in Nigeria, 2011\u20132017","volume":"6","author":"OB Salu","year":"2019","journal-title":"The Pan African Medical Journal"},{"issue":"6","key":"pone.0305521.ref011","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1128\/JCM.00170-17","article-title":"Laboratory diagnosis of Lassa fever","volume":"55","author":"V Raabe","year":"2017","journal-title":"Journal of Clinical Microbiology"},{"key":"pone.0305521.ref012","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1128\/JCM.01847-16","article-title":"High prevalence and diversity of hepatitis viruses in suspected cases of yellow fever in the Democratic Republic of Congo","volume":"55","author":"S Makiala-Mandanda","year":"2017","journal-title":"J Clinical Microbiology"},{"key":"pone.0305521.ref013","unstructured":"World Health Organization. Hepatitis E Key facts. 2020. Available from: Who.int\/news.room\/factsheets\/detail\/hepatitis E."},{"key":"pone.0305521.ref014","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/sjhs.sjhs_39_18","article-title":"Serological screening of hepatitis B virus and hepatitis C virus among patients attending a tertiary hospital in Jalingo, Taraba state, Nigeria","volume":"7","author":"V Omote","year":"2018","journal-title":"Saudi Journal Health Sci"},{"key":"pone.0305521.ref015","unstructured":"World Health Organization. What is hepatitis? An online question and answer reviewed September 2019."},{"key":"pone.0305521.ref016","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12879-017-2274-3","article-title":"Erratum to: A systematic review of the epidemiology of hepatitis E virus in Africa","volume":"17","author":"JH Kim","year":"2017","journal-title":"BMC Infect Dis"},{"key":"pone.0305521.ref017","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4103\/0255-0857.150908","article-title":"Prevalence of hepatitis A virus (HAV) and hepatitis E virus (HEV) in the patients presenting with acute viral hepatitis","volume":"33","author":"A Joon","year":"2015","journal-title":"Indian J Med Microbiol"},{"key":"pone.0305521.ref018","first-page":"2381","article-title":"Prevalence of Hepatitis E Virus infection among Blood donors in the Eastern Province of Saudi Arabia","author":"AA Reem","year":"2021","journal-title":"Journal of Multidisciplinary Healthcare"},{"key":"pone.0305521.ref019","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/17474124.2016.1185362","article-title":"Advances in hepatitis E - I: virology, pathogenesis, and diagnosis","volume":"10","author":"R Aggarwal","year":"2016","journal-title":"Expert Review Gastroenterology Hepatology"},{"key":"pone.0305521.ref020","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/trf.13976","article-title":"Hepatitis E risks: pigs or blood-that is the question","volume":"57","author":"RS Tedder","year":"2017","journal-title":"Transfusion"},{"key":"pone.0305521.ref021","doi-asserted-by":"crossref","first-page":"1700616","DOI":"10.2807\/1560-7917.ES.2018.23.35.1700616","article-title":"Current hepatitis E virus seroprevalence in Swiss blood donors and apparent decline from 1997 to 2016","volume":"23","author":"C Niederhauser","year":"2018","journal-title":"Euro Surveill"},{"issue":"6","key":"pone.0305521.ref022","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2217\/fvl-2021-0013","article-title":"Seroprevalence of the Hepatitis E Virus Antibodies Among Blood Donors in the Qassim region, Saudi Arabia","volume":"16","author":"BY Alhatlani","year":"2021","journal-title":"Future Virology"},{"key":"pone.0305521.ref023","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/vox.12846","article-title":"Hepatitis E virus infection in Hong Kong blood donors","volume":"115","author":"WC Tsoi","year":"2020","journal-title":"Vox Sang"},{"key":"pone.0305521.ref024","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0033-1338111","article-title":"Epidemiology of hepatitis E in low- and middle-income countries of Asia and Africa","volume":"33","author":"B Kmush","year":"2013","journal-title":"Semin Liver Dis"},{"issue":"1","key":"pone.0305521.ref025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12985-021-01607-y","article-title":"Hepatitis E virus prevalence among blood donors in Dali, China","volume":"18","author":"P Fu","year":"2021","journal-title":"Virol J"},{"key":"pone.0305521.ref026","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1111\/liv.12884","article-title":"Health disparities in liver disease in sub-Saharan Africa","volume":"35","author":"CW Spearman","year":"2015","journal-title":"Liver Int"},{"key":"pone.0305521.ref027","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4103\/0300-1652.137185","article-title":"Hepatitis A virus in West Africa: is an epidemiological transition beginning?","volume":"55","author":"KH Jacobsen","year":"2014","journal-title":"Niger Med J"},{"key":"pone.0305521.ref028","first-page":"9782892","article-title":"A Rare Presentation of Co-infection: Dengue Virus and Hepatitis A Virus","volume":"2019","author":"I Ranathunga","year":"2019","journal-title":"Case Rep Infect Dis"},{"key":"pone.0305521.ref029","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4269\/ajtmh.14-0196","article-title":"Hepatitis E as a cause of acute jaundice syndrome in northern Uganda, 2010\u20132012","volume":"92","author":"GB Gerbi","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"pone.0305521.ref030","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrgastro.2013.179","article-title":"HCV transmission in industrialized countries and resource-constrained areas","volume":"11","author":"M Thursz","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"pone.0305521.ref031","unstructured":"World Health Organization. \"Ebola virus disease Fact sheet No. 103\"; September 2014. Available from: https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/ebola-virus-disease."},{"issue":"4","key":"pone.0305521.ref032","doi-asserted-by":"crossref","first-page":"902","DOI":"10.4269\/ajtmh.15-0874","article-title":"Seroprevalence of Hepatitis B Infection in Nigeria: A National Survey","volume":"95","author":"AT Olayinka","year":"2016","journal-title":"Am J Trop Med Hyg"},{"issue":"13","key":"pone.0305521.ref033","doi-asserted-by":"crossref","first-page":"589","DOI":"10.12998\/wjcc.v6.i13.589","article-title":"Update on global epidemiology of viral hepatitis and preventive strategies","volume":"6","author":"M Jefferies","year":"2018","journal-title":"World Journal of Clinical Cases"},{"key":"pone.0305521.ref034","unstructured":"Centers for Disease Control and Prevention. Health disparities. Centers for Disease Control and Prevention, Division of Adolescent and School Health, National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention. 2020. Available from: https:\/\/www.cdc.gov\/healthyyouth\/disparities\/index.htm"},{"issue":"6","key":"pone.0305521.ref035","first-page":"9","article-title":"Prevalence Of Hepatitis C Positivity In Apparently Healthy Individuals In Akure, Nigeria","volume":"18","author":"EB Akande","year":"2020","journal-title":"Nat Sci"},{"key":"pone.0305521.ref036","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1473-3099(15)00006-7","article-title":"Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis","volume":"15","author":"VB Rao","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"pone.0305521.ref037","article-title":"Outbreak of lassa fever in Nigeria: measures for prevention and control","volume":"23","author":"KC Mofolorunsho","year":"2019","journal-title":"Pan African Medical Journal"},{"key":"pone.0305521.ref038","article-title":"Lassa fever: Unveiling the misery of the Nigerian health worker","author":"A. Mustapha","journal-title":"Ann Nigerian Med"},{"issue":"3","key":"pone.0305521.ref039","first-page":"155","volume":"9","author":"SE Amodu","year":"2019","journal-title":"Lassa fever and the Nigerian experience: a review European Journal of Biological Research"},{"key":"pone.0305521.ref040","unstructured":"Nigeria Centre for Disease Control (NCDC). An update of Lassa fever outbreak in Nigeria. 2019. [Accessed 1st November,2019]. https:\/\/ncdc.gov.ng\u203adiseases\u203asitreps."},{"issue":"12","key":"pone.0305521.ref041","doi-asserted-by":"crossref","first-page":"e0279467","DOI":"10.1371\/journal.pone.0279467","article-title":"Epidemiological trends of Lassa fever in Nigeria, 2018\u20132021","volume":"17","author":"MM Dalhat","year":"2022","journal-title":"PLoS ONE"},{"issue":"28","key":"pone.0305521.ref042","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.5897\/AJMR2017.8501","article-title":"Detection of Chikungunya and West Nile viruses in febrile patients in Ile-Ife Osun State, Nigeria using real time reverse transcription-polymerase chain reaction (RT-PCR)","volume":"11","author":"OA Adesina","year":"2017","journal-title":"African Journal of Microbiology Research"},{"key":"pone.0305521.ref043","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.actatropica.2016.04.007","article-title":"High rate of unrecognized dengue virus infection in parts of the rainforest region of Nigeria","volume":"160","author":"AB Onoja","year":"2016","journal-title":"Acta tropica"},{"issue":"1","key":"pone.0305521.ref044","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3844\/ajidsp.2013.7.10","article-title":"Serological evidence of recent dengue virus infection among febrile children in a semi-arid zone","volume":"9","author":"F Adedayo","year":"2013","journal-title":"American Journal of Infectious Diseases"},{"key":"pone.0305521.ref045","unstructured":"Nigeria Centre for Disease Control. National Guidelines on Infection Prevention and Control of Viral Haemorrhagic Fevers. NCDC Guidebook. 2017; 1\u201360."},{"key":"pone.0305521.ref046","unstructured":"Center for Disease Control. Prevention\/Isolation precaution\/ Guideline. 2016. Available from: cdc.gov\/prevention."},{"key":"pone.0305521.ref047","first-page":"321286","article-title":"Detection of Hepatitis C Virus Co-infection in Patients with Dengue Diagnosis","volume":"14","author":"C Machain-Williams","year":"2014","journal-title":"Biomed Research International"},{"key":"pone.0305521.ref048","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1186\/s12879-017-2840-8","article-title":"Identification of pathogens for differential diagnosis of fever with jaundice in the Central African Republic: A retrospective assessment, 2008\u20132010","volume":"17","author":"CLB Gadia","year":"2017","journal-title":"BMC Infectious Diseases"},{"key":"pone.0305521.ref049","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3390\/microbiolres12040064","article-title":"Prevalence and Diversity of Hepatitis Virus Markers among Patients with Acute Febrile Jaundice in Chad","volume":"12","author":"FH Yandai","year":"2021","journal-title":"Microbiol. Res"},{"issue":"8","key":"pone.0305521.ref050","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1086\/378747","article-title":"Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics","volume":"37","author":"TA Madani","year":"2003","journal-title":"Clin Infect Dis"},{"key":"pone.0305521.ref051","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/10408360490497474","article-title":"Yellow fever: the recurring plague","volume":"41","author":"O. Tomori","year":"2004","journal-title":"Critical Reviews in Clinical Laboratory Sciences"},{"issue":"9","key":"pone.0305521.ref052","doi-asserted-by":"crossref","first-page":"e1839","DOI":"10.1371\/journal.pntd.0001839","article-title":"Molecular diagnostics for Lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation","volume":"6","author":"DA Asogun","year":"2012","journal-title":"PLoS Neglected Tropical Disease"},{"issue":"4","key":"pone.0305521.ref053","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4103\/0972-5229.92073","article-title":"Concurrent infection of Dengue fever and Hepatitis A infection: A case report","volume":"15","author":"AS Zaki","year":"2011","journal-title":"Indian J. Crit. Care Med"},{"issue":"7","key":"pone.0305521.ref054","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.trstmh.2005.10.007","article-title":"Pathogenesis of liver involvement during dengue viral infections","volume":"100","author":"SL Seneviratne","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pone.0305521.ref055","unstructured":"World Health Organization. The global prevalence of hepatitis A virus infection and susceptibility: a systematic review. Geneva: 2020. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/70180\/WHO_IVB_10.01_eng.pdf?sequence=1."},{"key":"pone.0305521.ref056","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4254\/wjh.v4.i3.68","article-title":"Hepatitis A: Epidemiology and prevention in developing countries","volume":"4","author":"E Franco","year":"2012","journal-title":"World Journal of Hepatology"},{"key":"pone.0305521.ref057","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.2196\/publichealth.7370","article-title":"Viral Hepatitis Strategic Information to Achieve Elimination by 2030: Key Elements for HIV Program Managers","volume":"3","author":"Y Hutin","journal-title":"JMIR Public Health and Surveillance"},{"issue":"3","key":"pone.0305521.ref058","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4103\/1118-8561.145413","article-title":"Seroprevalence of Hepatitis E infection among secondary school students in Kaduna State, Northern Nigeria","volume":"14","author":"MA Bugaje","year":"2011","journal-title":"Sahel Medical Journal"},{"key":"pone.0305521.ref059","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/hep.25505","article-title":"The global burden of hepatitis E virus genotypes 1 and 2 in 2005","volume":"55","author":"DB Rein","year":"2012","journal-title":"Hepatology"},{"issue":"2","key":"pone.0305521.ref060","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nrgastro.2017.150","article-title":"Hepatitis E virus: advances and challenges","volume":"15","author":"I Nimgaonkar","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"pone.0305521.ref061","first-page":"1","article-title":"Acute Hepatitis E virus infection in two geographical regions of Nigeria","volume":"10","author":"IM Ifeorah","year":"2017","journal-title":"Hindawi Journal of pathogens"},{"key":"pone.0305521.ref062","first-page":"15","article-title":"Epidemiology and associated risk factors of hepatitis E virus infection in Plateau State, Nigeria","volume":"5","author":"SA Junaid","year":"2014","journal-title":"Virology"},{"issue":"4","key":"pone.0305521.ref063","first-page":"62","article-title":"Detection of Hepatitis E virus among HIV infected individuals in Ogbomoso, South-western Nigeria","volume":"2","author":"EK Oladipo","year":"2017","journal-title":"British Journal of Virology"},{"key":"pone.0305521.ref064","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2472-1654.10005","article-title":"Olaleye. Serological Evidence and Risk Factors Associated With Hepatitis E Virus Infection in Pigs and Human at an Intensive Piggery Complex, Lagos Nigeria","volume":"1","author":"M Clement","year":"2016","journal-title":"Journal of Healthcare Communication"},{"key":"pone.0305521.ref065","doi-asserted-by":"crossref","first-page":"120","DOI":"10.11604\/pamj.2015.20.120.5501","article-title":"Seroprevalence and predictors of hepatitis A infection in Nigerian children","volume":"20","author":"JM Ikobah","year":"2015","journal-title":"Pan African Medical Journal"},{"issue":"2","key":"pone.0305521.ref066","doi-asserted-by":"crossref","first-page":"62","DOI":"10.5897\/AJMR2015.7737","article-title":"Sero-prevalence of Hepatitis C Virus in HIV Seropositive Children in Lagos, Nigeria","volume":"10","author":"AOB Oyefolu","year":"2016","journal-title":"African Journal of Microbiology Research"},{"issue":"2","key":"pone.0305521.ref067","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4314\/ajcem.v19i2.8","article-title":"Co-infection of Hepatitis B and C viruses among human immunodeficiency virus infected children in lagos, nigeria","volume":"19","author":"OB Salu","year":"2018","journal-title":"African Journal of Clinical and Experimental Microbiology"},{"issue":"10","key":"pone.0305521.ref068","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.3889\/oamjms.2019.143","article-title":"Hepatitis E Infection in Nigeria: A systematic Review","volume":"7","author":"HI Okagbue","year":"2019","journal-title":"Open Access Macedonian Journal of Medical Sciences"},{"issue":"3","key":"pone.0305521.ref069","first-page":"1","article-title":"Seroprevalence of hepatitis E among restaurant food handlers in Ibadan","volume":"20","author":"A Fowotade","year":"2018","journal-title":"Tanzania journal of health"},{"key":"pone.0305521.ref070","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1128\/CVI.00255-06","article-title":"Community-based seroepidemiological survey of hepatitis E virus infection in Catalonia, Spain","volume":"13","author":"M Buti","year":"2006","journal-title":"Clinical Vaccine Immunology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0305521","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T17:51:04Z","timestamp":1718992264000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0305521"}},"subtitle":[],"editor":[{"given":"Daniel Oladimeji","family":"Oluwayelu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,6,21]]},"references-count":70,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0305521","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,21]]}}}